[Skip to Content]
[Skip to Content Landing]
Article
July 1980

Choroidal Melanoma

Author Affiliations

USA
Washington, DC

Arch Ophthalmol. 1980;98(7):1298-1301. doi:10.1001/archopht.1980.01020040150028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.  —Drs Manschot and van Peperzeel (Archives 98:71-77, 1980) have presented a model based on tumor doubling time for the study of uveal melanomas. While we find this kind of model useful in trying to understand the behavior of tumors, we believe that theirs is an oversimplification and that some of the assumptions they have built into the model are not applicable to uveal melanomas. Unfortunately, these simplifications and assumptions profoundly affect the conclusions reached regarding the behavior of uveal melanomas.The first assumption we question is that melanomas in metastatic sites grow at the same rate as does the primary intraocular tumor. From our experience with cases that underwent autopsy in which death occurred before any therapy, we know that metastatic tumors grow faster than the primary intraocular melanoma. In these cases,1 the metastases have grown to a combined weight of several kilograms, while the intraocular

References
1.
Zimmerman LE,  McLean IW: Metastatic disease from untreated uveal melanomas . Am J Ophthalmol 88:524-534, 1979.
2.
Ruiz RS:  Early treatment in malignant melanoma of the choroid , in Brockhurst RJ, Boruchoff SA, Hutchinson BT, et al (eds): Controversy in Ophthalmology . Philadelphia, WB Saunders Co, 1977, pp 604-610.
3.
Davies JNP:  Overview of the biology and pathology of metastasis , in Day SB, Myers WPL, Stansly P, et al (eds): Progress in Cancer Research and Therapy. Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy . New York, Raven Press, 1977, vol 5, pp 13-18.
4.
Benjamin B, Cumings JN, Goldsmith AJB, et al:  Prognosis in uveal melanoma . Br J Ophthalmol 32:729-747, 1948.Article
5.
Paul EV, Parnell BL, Fraker M:  Prognosis of malignant melanoma of the choroid and ciliary body . Int Ophthalmol Clin 2:387-402, 1962.Article
6.
Jensen OA:  Malignant melanomas of the uvea in Denmark, 1943-1952: A clinical, histopathological and prognostic study . Acta Ophthalmol Suppl 75:141-152, 1963.
7.
Lucké B, Breedis C, Woo ZP, et al:  Differential growth of metastatic tumors in liver and lung: Experiments with rabbit V2 carcinoma . Cancer Res 12:734-738, 1952.
8.
Nicolson GL:  Cancer metastasis . Sci Am 240:66-76, 1979.Article
9.
Leighton J:  Invasion and metastasis of heterologous tumors in the chick embryo . Progr Exp Tumor Res 4:98-125, 1964.
10.
Fidler IJ, Kripke ML:  Metastasis results from preexisting variant cells within a malignant tumor . Science 197:893-895, 1977.Article
11.
Nicolson GL, Brunson KW, Fidler IJ:  Specificity of arrest, survival, and growth of selected metastatic variant cell lines . Cancer Res 38:4105-4111, 1978.
12.
Fidler IJ, Gersten DM, Hart IR:  The biology of cancer invasion and metastasis . Adv Cancer Res 28:149-250, 1978.
13.
Kinsey DL:  An experimental study of preferential metastasis . Cancer 13:674-676, 1960.Article
14.
Fidler IJ, Nicolson GL:  Organ selectivity for implantation, survival, and growth of B16 melanoma variant cell lines . J Natl Cancer Inst 57:1199-1202, 1976.
15.
Brunson KW, Beattie G, Nicolson GL:  Selection and altered tumour cell properties of brain-colonizing metastatic melanoma . Nature 272:543-545, 1978.Article
16.
Simpson-Herren L, Lloyd HH:  Kinetic parameters and growth curves for experimental tumor systems . Cancer Chemother Rep 54( (pt 1) ):143-174, 1970.
17.
Norton L, Simon R:  Predicting the course of Gompertzian growth . Nature 264:542-545, 1976.Article
18.
Steel GG: Growth Kinetics of Tumours: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer . Oxford, England, Clarendon Press, 1977, pp 5-55.
19.
Norton L, Simon R:  Growth curve of an experimental solid tumor following radiotherapy . J Natl Cancer Inst 58:1735-1741, 1977.
20.
McLean IW, Zimmerman LE, Martin D, et al:  Use of the inferred natural history of uveal melanoma to evaluate the effect of enucleation on patient survival , abstracted. Invest Ophthalmol 18( (suppl) ):121, 1979.
21.
McLean IW, Foster WD, Zimmerman LE, et al: Inferred natural history of uveal melanoma. Invest Ophthalmol, to be published.
×